Drugs / Amoxycillin/clavulanic acid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02349841 Background | Sep → Dec 2014 | pulmonary tuberculosis | TASK Applied Science | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxycillin/clavulanic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02349841 ↗ |
| Route | Oral | “amoxycillin/CA 500mg/125mg orally 8- hourly” NCT02349841 ↗ |